Oracle's purchase of Relsys Intl. will boost its health software offerings
Oracle has acquired Relsys International Inc., which produces drug safety and risk management analytics software, in a deal that is expected to close in the first half of this year. Terms of the deal were not disclosed.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.